EVOFIX

This brand name is authorized in Nigeria.

Active ingredients

The drug EVOFIX contains one active pharmaceutical ingredient (API):

1	Cefixime UNII 97I1C92E55 - CEFIXIME
	Cefixime is an oral third generation cephalosporin which has marked in vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organisms.
	Read more about Cefixime

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
C4-0369	Capsule	EVOFIX 400MG CAPSULES CAP 400 mg 1 X 5	EVOFIX 400MG CAPSULES EVOFIX CEFIXIME 400MG POM CAPSULE 1 X 5 ANTIBIOTIC FENSYL MHP CONSULTING LTD., 49 KOFO ABAYOMI STREET, APAPA LAGOS. PHARMEVO PVT. LIMITED PLOT A-29 , NORTH WESTERN INDUSTRIAL ZONE, PORT QASIM, KARACHI-75020, PAKISTAN. GMP- SATIS; LR- SATIS; FEES- PAID; NP:NA 07/02/2018 C4-0369	30/01/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD08	Cefixime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	C4-0369